Skip to main content
LABORATORIOS RICHMOND SOCIEDAD ANONIMA, COMERCIAL, logo

LABORATORIOS RICHMOND SOCIEDAD ANONIMA, COMERCIAL, — Investor Relations & Filings

ISIN · ARRICHM01019 BYMA Manufacturing
Open in API
Filings indexed 1,144 across all filing types
Latest filing 2026-05-14 Director's Dealing
Country AR Argentina
Listing BYMA

About LABORATORIOS RICHMOND SOCIEDAD ANONIMA, COMERCIAL,

https://richmondlab.com/

Laboratorios Richmond is a pharmaceutical company focused on the development and manufacture of technologically advanced pharmaceutical products. The company specializes in therapeutic areas including HIV medicine, oncology, oncohematology, and cardiometabolism. Its product portfolio encompasses generic products, biosimilars, and licensed technologies. Utilizing state-of-the-art technology, Laboratorios Richmond is committed to ensuring high quality and facilitating equitable access to therapeutic solutions. The company also develops innovative formulations, such as combined active principles in single tablets, and patient-friendly packaging designed to improve therapeutic adherence and patient quality of life. It serves markets across Latin America, Africa, and Asia.

Recent filings

Filing Released Lang Actions
INFORMA ADQUISICIÓN DE ACCIONES CLASE B - MARCELO R. FIGUEIRAS
Director's Dealing Classification · 90% confidence The document is an insider transaction notice where the President of the Board acquired 1,500,000 Class B shares. It is a personal share transaction by a company director, matching the criteria for Director’s Dealing filings.
2026-05-14 Spanish
ORGANO DISTRIB.: ASAMBLEA - FEC. RESOLUC.: 30-04-2026 - TIPO PAGO: EN EFECTIVO - PAGO DE DIVIDENDOS
Notice of Dividend Amount Classification · 95% confidence The document is a formal notice to shareholders regarding the payment of cash dividends, specifying the approved dividend amounts, per-share value, payment schedule (two installments on May 15 and June 15, 2026), and payment procedures. This matches the definition for a Notice of Dividend Amount rather than a corporate report or other filing.
2026-05-08 Spanish
FEC. CELEB.: 30-04-2026 - APRUEBA EECC: SI - ACTA DE ASAMBLEA Y/O REUNIÓN DE SOCIOS03
AGM Information Classification · 95% confidence The document is the official “Acta de Asamblea General Ordinaria” (minutes of the Annual General Meeting) for LABORATORIOS RICHMOND S.A.C.I.F., detailing attendance, quorum, agenda items, votes, resolutions, and procedural formalities. It is not merely a notice or voting result summary but the complete AGM minutes, fitting the “AGM Information” category (materials from the AGM).
2026-05-08 Spanish
FEC. CELEB.: 07-05-2026 - TEMA: 5 - ACTA DE ÓRGANO DE ADMINISTRACIÓN (DIRECTORIO)
Governance Information Classification · 85% confidence The document is the minutes (Acta) of a board meeting of Laboratorios Richmond S.A.C.I.F., held on May 7, 2026, recording quorum, attendees, and the unanimous approval of interim financial statements for the quarter ended March 31, 2026. It does not present the financial statements themselves (so it isn’t an Interim/Quarterly Report), nor is it announcing changes in management (so not MANG), nor simply publishing a report. Instead, it is a governance record of internal board proceedings, which best fits the Governance Information category (CGR).
2026-05-07 Spanish
FEC. CELEB.: 07-05-2026 - TEMA: APROBACIÓN DE EECC - ACTA ORGANO DE FISCALIZACIÓN
Audit Report / Information Classification · 88% confidence The document is the minutes and review report issued by the Supervisory Committee (“Comisión Fiscalizadora”) on the interim (quarterly) consolidated and separate financial statements for the three months ended March 31, 2026, including reference to the external auditor’s limited review. It is not the interim report itself, nor merely an announcement; it is a standalone attestation/audit‐type report on those financial statements. This matches the definition of a standalone audit/review report (Audit Report / Information). Q1 2026
2026-05-07 Spanish
INFORME DE RESULTADOS 1T2026 LABORATORIOS RICHMOND
Interim / Quarterly Report Classification · 98% confidence The document is titled “Informe de Resultados 1T Año 2026” and contains full consolidated financial statements (balance sheet, income statement, cash flows, segments) and detailed commentary on first‐quarter performance. It covers a three‐month interim period ended March 31, 2026 and includes substantive financial data and analysis rather than merely announcing results. This matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-07 Spanish

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.